THE IMMUNOBIOLOGY OF CARCINOGENESIS (EVANS)
THE IMMUNOBIOLOGY OF CARCINOGENESIS (EVANS)
批准号:
6289069
负责人:
CHARLES ROBERT EVANS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
戏剧性和特征性组织的致病基础
与自身免疫性Graves病相关的重塑
眼病最有可能在于成纤维细胞的相互作用
免疫活性细胞,包括B和T淋巴细胞、肥大细胞
和单核细胞。这些细胞一旦被贩卖到轨道上
启动导致成纤维细胞活化和积聚的过程
透明质酸正是透明质酸的高度亲水性,
导致眼眶内容物部分挤出,
眼球突出的表现。Leukoregulin,一种50千道尔顿的抗癌药物
由淋巴细胞分泌的细胞因子,可以通过以下方式增加透明质酸的合成:
在眼眶成纤维细胞中超过15倍。这件事的重要性
这种增加在哺乳动物细胞系统中是前所未有的,
白细胞调节蛋白作为激活的候选分子触发剂,
Graves眼病中的眼眶成纤维细胞另一个引人注目的特点是
活动期的眼病是一种强烈的炎症反应,
反应Leukoregulin显著增加前列腺素E2(PGE 2)
在眼眶成纤维细胞中合成;这种上调是通过
- 诱导牛肝菌素-内过氧化物H合酶-2(PGHS-2),
炎性环氧化酶PGHS-2表达的增加引起了
白细胞调节素在眼眶成纤维细胞中的作用可能是两者共同作用的结果。
转录和转录后效应。这些观察结果
有助于阐明与强烈的
与Graves眼病相关的炎症。淋巴细胞
被贩运到眼眶组织中,通过
它们释放的细胞因子,
自身免疫性疾病眼眶成纤维细胞的高敏感性
白细胞调节素的差异基因调节作用,此外,
让人想起宫颈癌、白血病和其他
肿瘤细胞对这种细胞因子。因此,眼眶成纤维细胞可能
为细胞因子应答性肿瘤的研究提供了独特的新资源
细胞属性和标记。
英文摘要
The pathogenic basis for the dramatic and characteristic tissue
remodeling associated with the autoimmuine disease Graves'
ophthalmopathy most likely resides in the interaction of fibroblasts
with immunocompetent cells, including B and T lymphocytes, mast cells
and monocytes. Once trafficked to the orbit these cells apparently
initiate processes leading to fibroblast activation and the accumulation
of hyaluronan. It is the profound hydrophilicity of hyaluronan that
results in the partial extrusion of orbital contents and the
manifestation of proptosis. Leukoregulin, a 50 kiloDalton anti-cancer
cytokine secreted by lymphocytes, can increase hyaluronan synthesis by
greater than 15-fold in orbital fibroblasts. The magnitude of this
increase is unprecedented in mammalian cell systems and implicates
leukoregulin as a candidate molecular trigger in the activation of
orbital fibroblasts in Graves' ophthalmopathy. Another striking feature
of the active phase of ophthalmopathy is an intense inflammatory
reaction. Leukoregulin dramatically increases prostaglandin E2 (PGE2)
synthesis in orbital fibroblasts; this up-regulation is mediated through
an induction of prostaglandin-endoperoxide H synthase-2 (PGHS-2), the
inflammatory cycoloxygenase. The increased PGHS-2 expression elicited
by leukoregulin in orbital fibroblasts may be a consequence of both
transcriptional and post-transcriptional effects. These observations
help clarify the pathogenic mechanisms relevant to the intense
inflammation associated with Graves' ophthalmopathy. Lymphocytes
trafficked to orbital tissues have a putative role, through the
cytokines they release, in the activation of fibroblasts in this
autoimmune disease. The heightened sensitivity of orbital fibroblasts
to the differential gene regulatory action of leukoregulin, moreover,
is reminiscent of the response of cervical carcinoma, leukemia and other
tumor cells to this cytokine. Orbital fibroblasts, therefore, may
provide a unique new resource for the study of cytokine responsive tumor
cell properties and markers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Meta-Analysis of Metabolic Determinants of Exercise Response in Common Funds Data
-
批准号:10772237
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2023
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Michigan Compound Identification Development Cores (MCIDC)
-
批准号:10012966
-
项目类别:
-
资助金额:$19.26万
-
财政年份:2018
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Michigan Compound Identification Development Cores (MCIDC)
-
批准号:10257642
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2018
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Experimental Core
-
批准号:10183255
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2018
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Administrative Core
-
批准号:10183253
-
项目类别:
-
资助金额:$15.26万
-
财政年份:2018
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Inter-lab comparison of unknowns in polar metabolomics data
-
批准号:10397327
-
项目类别:
-
资助金额:$39.17万
-
财政年份:2018
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Michigan Compound Identification Development Cores (MCIDC)
-
批准号:10183251
-
项目类别:
-
资助金额:$84.57万
-
财政年份:2018
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Michigan Compound Identification Development Cores (MCIDC)
-
批准号:9764380
-
项目类别:
-
资助金额:$86.64万
-
财政年份:2018
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Experimental Core
-
批准号:9589598
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2018
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Metabolic flux in a model of reduced oxidative capacity
-
批准号:8279343
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2011
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Metabolic flux in a model of reduced oxidative capacity
-
批准号:8663248
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2011
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Metabolic flux in a model of reduced oxidative capacity
-
批准号:8165033
-
项目类别:
-
资助金额:$13.97万
-
财政年份:2011
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Metabolic flux in a model of reduced oxidative capacity
-
批准号:8462126
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2011
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Administrative Core
-
批准号:9764382
-
项目类别:
-
资助金额:$13.67万
-
财政年份:--
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
Experimental Core
-
批准号:9764385
-
项目类别:
-
资助金额:$44.19万
-
财政年份:--
-
负责人:CHARLES ROBERT EVANS
-
依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: